Crown Bioscience Inc.
Laurie Heilmann Named President of New CrownBio Global Life Science and Diagnostic Solutions Division
SAN DIEGO, June 06, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience , a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, today announces the appointment of Laurie Heilmann as President of CrownBio Global Life Science Product and Diagnostic Solutions. Heilmann will lead the newly formed division to achieve its mission of enabling scientists to access, discover and develop revolutionary drugs and diagnostics by providing cutting-edge solutions that transform scientific ideas into reality.
"Laurie is a dynamic and visionary leader with an impressive record of success building and accelerating innovative biotechnology companies on a global scale," said Jean-Pierre Wery, Ph.D., Crown Bioscience Chief Executive Officer. "As President of CrownBio Global Life Science and Diagnostic Solutions Division, Laurie will spearhead strategy development and commercialization of a unique portfolio of products and services that supports clinical and diagnostic markets across several therapeutic concentrations, including oncology, inflammation, cardiovascular, metabolic and neurological diseases."
"This is an exciting opportunity to propel CrownBio Global Life Science and Diagnostic Solutions to a market leader position in life science and diagnostic spaces," said Laurie Heilmann, former Chief Business Officer at Crown Bioscience. "It is a pivotal time in the industry as we move forward with game-changing products and services that support research from concept through commercialization and enable scientists to access, discover and develop innovative drugs and diagnostics across several therapeutic areas."
Laurie possesses a diverse therapeutic background and has over three decades of global experience aligning sales and marketing with R&D to steer company strategy. As President of CrownBio Life Science Products and Diagnostics, Laurie will be responsible for charting new inroads of scientific and technological advancements to meet the needs of clinical and diagnostic markets across several therapy areas.
About Crown Bioscience Inc.
Crown Bioscience is a global drug discovery and development solutions company providing translational platforms to advance oncology, inflammation, and metabolic disease research. With an extensive portfolio of relevant models and predictive tools, Crown Bioscience enables clients to deliver superior clinical candidates.
Crown Bioscience Inc. firstname.lastname@example.org
Information om Globenewswire
Følg pressemeddelelser fra Globenewswire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Globenewswire
DoubleVerify11.12.2018 18:05 | Pressemeddelelse
DoubleVerify and InMobi Unite to Combat Mobile App Fraud
Claroty11.12.2018 15:03 | Pressemeddelelse
Claroty Announces Major Enhancements to Market-Leading Industrial Cybersecurity Platform
Farmako GmbH11.12.2018 10:01 | Pressemeddelelse
Farmako: Cannabis distributor to become gateway to Europe
Graduate Management Admission Council10.12.2018 16:28 | Pressemeddelelse
The Graduate Management Admission Council Selects Three New Business Schools for Membership
CereSpir Inc.10.12.2018 15:01 | Pressemeddelelse
CERESPIR INCORPORATED and the NATIONAL NEUROSCIENCE INSTITUTE SINGAPORE Announce Positive Data Showing Beneficial Effects of CERESPIR’s Clinical Stage Compound Itanapraced in a LRRK2 Model of Parkinson’s Disease
Centrient Pharmaceuticals10.12.2018 13:31 | Pressemeddelelse
DSM Sinochem Pharmaceuticals announces its new name - Centrient Pharmaceuticals
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.Besøg vores nyhedsrum